Clinical Trial Update: A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating the safety and tolerability of SBO-154 in patients with advanced solid tumors, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SBO-154

Snippet

Sponsor: Sun Pharma Advanced Research Company Limited | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING